纽约大学阿布扎比分校与克利夫兰诊所合作开发了一种可注射的神经调控装置，用于治疗慢性疼痛和运动障碍1。该设备体积仅约芝麻粒大小，可通过标准注射针注入体内，采用体外无线供电方式，无需手术、电池或连接线1。医生或患者能够实时调节刺激参数，并可通过超声和CT扫描对设备进行定位和监测1。
这项研究已发表在2026年10月的《科学进展》杂志上1。在体内动物实验中，该设备成功激活了神经1。研究团队负责人Khalil Ramadi教授表示："通过创造可注射而非手术植入的设备，我们使这些疗法更简单、更安全、更易获得"1。
目前，该技术仅完成了早期实验室测试和临床前测试，人体有效性尚未确立1。
Researchers at New York University Abu Dhabi and Cleveland Clinic have created a wireless-powered injectable neuromodulation device roughly the size of a sesame seed, designed to precisely control nerve activity for treating chronic pain and movement disorders 1. The device can be injected through a standard needle without requiring surgery, batteries, or physical connections 1. Doctors or patients can adjust stimulation parameters in real time using external wireless power, and the implant can be located and monitored using ultrasound and CT imaging 1.
The technology has been published in Science Advances in October 2026 and has demonstrated success in activating nerves during early laboratory and animal testing phases 1. According to Professor Khalil Ramadi, "By creating devices that are injectable rather than surgically implanted, we have made these therapies simpler, safer, and more accessible" 1. However, the researchers acknowledge that while preclinical tests have shown promise, the device's effectiveness in human patients remains to be established through further clinical validation 1.
评论
还没有评论，欢迎留下第一条。